New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Chemgenex Pharmaceuticals (CXSP)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
30-JUN
2007
30-SEP
2007
31-DEC
2007
31-MAR
2008
30-JUN
2008
Total Revenue
176K
281K
278K
193K
240K
Cost of Revenue
0
0
26.9K
0
0
Gross Profit
176K
281K
251K
193K
240K
Research & Development
0
0
1.77M
0
0
SG&A
0
0
2.15M
0
0
Amortization & Deprec
0
0
0
0
0
Other Expenses
176K
281K
-6.08M
193K
240K
Total Operating Expenses
176K
281K
-2.16M
193K
240K
Operating Income
0
0
2.41M
0
0
Other Income
-
-
629K
-
-
EBIT
-3.63M
-3.05M
3.04M
-4.80M
-5.57M
Minority Interest
0
0
0
0
0
Interest Expense
0
0
0
0
0
Income Before Taxes
-3.63M
-3.05M
3.04M
-4.80M
-5.57M
Income Taxes
0
0
-31.1K
0
0
Net Income from Continuing Ops
-3.63M
-3.05M
3.07M
-4.80M
-5.57M
Income - Discontinued Ops
0
0
0
0
10.5M
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
-3.63M
-3.05M
3.07M
-4.80M
4.93M
Preferred Dividends
0
0
0
0
0
Net Income to Common
-3.63M
-3.05M
-3.01M
-4.80M
4.93M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour